5 patents
Utility
Xanomeline derivatives and methods for treating neurological disorders
27 Dec 22
James A. Monn, Clifford Adam Schlecht, Dennis A. Bennett, Giorgio Attardo
Filed: 16 Nov 20
Utility
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
18 Oct 22
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
Aimesther Betancourt, Bruce Rehlaender, Roch Thibert
Filed: 7 Jan 21
Utility
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
27 Sep 22
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
Aimesther Betancourt, Bruce Rehlaender, Roch Thibert
Filed: 3 Feb 22
Utility
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
2 Mar 21
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof, and a plurality of trospium beads having a core comprising a salt of trospium.
Aimesther Betancourt, Bruce Rehlaender, Roch Thibert
Filed: 27 Sep 19
Utility
Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activation
23 Feb 21
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
Aimesther Betancourt, Bruce Rehlaender, Roch Thibert
Filed: 21 May 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first